Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 99.82 million compared to CNY 160.11 million a year ago. Revenue was CNY 99.82 million compared to CNY 160.11 million a year ago. Net loss was CNY 15.13 million compared to CNY 4.12 million a year ago. Basic loss per share from continuing operations was CNY 0.1242 compared to CNY 0.0338 a year ago. Diluted loss per share from continuing operations was CNY 0.1242 compared to CNY 0.0338 a year ago.